Pulsed Dye Laser and Affirm Laser in the Treatment of Abdominoplasty Scars

NCT ID: NCT00735254

Last Updated: 2018-02-08

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

3 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-07-31

Study Completion Date

2010-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine the effect of using a pulsed dye laser (the VBEAM), a non-ablative laser (the Affirm) and a combination of both lasers to improve the appearance of your surgical scar. Both the pulsed dye laser and Affirm laser are approved by the US Food and Drug Administration (FDA) for the treatment of scars. Surgical scars are a type of scar that can benefit from laser therapy. Redness and the appearance of small blood vessels near the surface of the skin (telangiectasias) develop in such scars as part of the normal healing process and usually spontaneously remit, but often slowly and incompletely. In many cases, lasers can accelerate the clearing of this redness and also improve scar texture.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In summary, we will perform a total of three laser treatments. A personal interview, clinical examination, and a photograph will be taken at each visit. At the end of the three treatments, a final personal interview, clinical evaluation and photograph will be taken to document the effects of the laser treatments. At the end of the study, the patient will have the option to receive two additional laser treatments four weeks apart, also at no cost, to the entire scar.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Abdominoplasty Scars

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pulsed dye laser

PDL Patient will be have scar treated with pulsed dye laser.

Group Type ACTIVE_COMPARATOR

pulsed dye laser

Intervention Type DEVICE

patient will have scar treated with pulsed dye laser

Affirm laser

Patient will be have scar treated with Affirm Laser

Group Type ACTIVE_COMPARATOR

Affirm Laser

Intervention Type DEVICE

patient will have scar treated with Affirm laser

combined PDL and Affirm Lasers

Patient will be have scar treated with combined Affirm + PDL

Group Type ACTIVE_COMPARATOR

combined PDL and Affirm Lasers

Intervention Type DEVICE

patient will have scar treated with Affirm and pulsed dye lasers

Placebo

Patient will be have scar treated with Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

patient will receive no treatment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pulsed dye laser

patient will have scar treated with pulsed dye laser

Intervention Type DEVICE

Affirm Laser

patient will have scar treated with Affirm laser

Intervention Type DEVICE

combined PDL and Affirm Lasers

patient will have scar treated with Affirm and pulsed dye lasers

Intervention Type DEVICE

Placebo

patient will receive no treatment

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

VBEAM non-ablative laser VBEAM, non-ablative laser

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 years and older
* No significant medical illness
* Surgical procedure that involves closure of the transverse abdominal incision performed in the department of dermatology and plastic surgery at the Cleveland Clinic main campus.
* Subjects with the willingness and ability to understand and provide informed consent

Exclusion Criteria

* Under 18 years of age
* Pregnancy or Lactation
* Subjects currently taking blood thinners or who have had chemotherapy or radiation within the last 6 months
* Subjects with liver/kidney disease, diabetes mellitus, hypertension, connective tissue disease or who are immunocompromised
* Subjects with a known susceptibility to keloid formation or hypertrophic scarring
* Subjects who are unable to understand the protocol or to give informed consent
* Subjects with mental illness
* Subjects with obvious non-healing wound
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Cleveland Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rebecca Tung, MD

Role: STUDY_DIRECTOR

The Cleveland Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cleveland Clinical Foundation

Cleveland, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

08-352

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Stretch Marks on Abdomen
NCT03750422 UNKNOWN NA